Evidence map›Paper›PMID 33947744›Full record

ReviewCancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology2021

Cancer Progress and Priorities: Breast Cancer.

Serena C Houghton, Susan E Hankinson

Abstract readReview
In one paragraph

Review in Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 91 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
91citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

91 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Trial
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Review
  20. Article

31 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Serena C HoughtonDepartment of Biostatistics and Epidemiology, University of Massachusetts Amherst, Amherst, Massachusetts. Shoughto@schoolph.umass.edu.
Susan E HankinsonDepartment of Biostatistics and Epidemiology, University of Massachusetts Amherst, Amherst, Massachusetts.

Funding

Endogenous hormones and postmenopausal breast cancer: Etiologic insights and improving risk predictionR01CA207369 · NCI · UNIVERSITY OF MASSACHUSETTS AMHERST · PI HANKINSON, SUSAN E · 2017 to 2021
$4.5M
Central Obesity in Relation to Breast Cancer Risk and SurvivalF32CA224677 · NCI · UNIVERSITY OF MASSACHUSETTS AMHERST · PI HOUGHTON, SERENA CATHERINE · 2018 to 2020
$196k
NCI NIH HHS F32 CA224677NCI NIH HHS R01 CA207369
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

BiomarkersBreast NeoplasmsFemaleGlobal HealthHealth Status DisparitiesHumansIncidenceRisk FactorsUnited StatesWomen's HealthBiomarkers

Identifiers

PMID33947744
PMCPMC8104131

What Socratic holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.